Annamycin has the potential to be safer and more effective than current prescribed anthracyclines to treat serious, ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin” or the "Company”), a late-stage pharmaceutical company with a broad ...

Heron Therapeutics, Inc.’s HRTX share price has dipped by 10.61%, which has investors questioning if this is right time to buy.